Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2021-09-14 00:00:00 ET · period of report 2021-09-13 · accession 0001209191-21-055966 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-09-14 | 2021-09-13 | ARWR | OLUKOTUN ADEOYE Y | Dir | S - Sale | $63.76 | -5,000 | 9,000 | -36% | -$318.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-13 | S | D | 2,250 | $63.76 | 11,750 | D | — | — | (F2) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions. |
| 2 | Common | Common Stock | 2021-09-13 | S | D | 2,750 | $63.76 | 9,000 | D | — | — | (F2) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person which are subject to certain vesting conditions. |